Director Shareholding

GlaxoSmithKline PLC
02 July 2004




                              Directors' Interests



I give below details of changes in the directors' interests in the Ordinary
Shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.



On 1 July 2004, the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and ADSs in the Company
under the automatic share allocation arrangements for non-executive Directors
for the period of service from 1 April to 30 June 2004, as listed below.


Non Executive Director                     Ordinary Shares        American Depository Shares
                                                                             (ADS)
Sir Christopher Hogg                            1,500
Sir Christopher Gent                           435.3041
Mr Lawrence Culp                                                              125
Mr Crispin Davis                                 250
Sir Peter Job                                    250
Sir Ian Prosser                                  250
Dr Ronaldo Schmitz                               250
Dr Lucy Shapiro                                                               125
Sir Robert Wilson                                250


At the same time the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and ADSs in the Company
under the share election element of the share allocation arrangements for
non-executive Directors for the period of service from 1 April to 30 June 2004,
as listed below.




Non Executive Director                     Ordinary Shares        American Depositary Shares

                                                                             (ADS)

Sir Christopher Hogg                          3,301.0563
Mr Lawrence Culp                                                           430.0048
Mr Crispin Davis                               990.3169
Sir Peter Job                                  990.3169
Sir Ian Prosser                                495.1585
Dr Ronaldo Schmitz                             484.1549



The Company and the directors were informed of these allocations on 1 July 2004.



S M Bicknell

Company Secretary

2 July 2004


                      This information is provided by RNS
            The company news service from the London Stock Exchange